Saia John G. 4
4 · Guardant Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CLO John Saia Receives 20,448 RSU Award
What Happened
- John G. Saia, Chief Legal Officer of Guardant Health, received an award of 20,448 restricted stock units (RSUs) on March 11, 2026. The grant is reported as an acquisition (award) at $0.00 per share (derivative award), meaning no cash was paid for the shares when granted.
Key Details
- Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely).
- Transaction code: A (award/grant); reported price: $0.00.
- Vesting: 33% vests on April 1, 2027; remaining 67% vests in equal quarterly installments over the subsequent two years (three-year total vesting schedule). (Footnote F1)
- Footnote F2: "Not applicable for Restricted Stock Units." (as noted in the filing)
- Shares owned after the transaction: not disclosed in the provided filing details.
Context
- This was a compensation award (RSUs), not a market purchase or sale, so it reflects a grant of future shares tied to a vesting schedule rather than an immediate buy or sell. RSUs typically convert to shares upon vesting and are usually taxable as ordinary income at that time. The filing shows the grant was reported promptly.
Insider Transaction Report
Form 4
Saia John G.
Chief Legal Officer
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-11+20,448→ 20,448 totalExercise: $0.00→ Common Stock (20,448 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F2]Not applicable for Restricted Stock Units.
Signature
/s/ John G. Saia|2026-03-13